Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01485666 · ClinicalTrials.gov registry record
Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 50
- Enrollment target
NCT01485666 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 50 participants.
The verdict
NCT01485666 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility of a Percutaneous Lead Management Kit for HeartMate II driveline stabilization and exit site management.
Interventions
- OTHER Percutaneous Lead Management Kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-05 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01485666
The ClinicalTrials.gov registry entry for NCT01485666 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous Lead Management Kit is the first listed.
NCT01485666 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01485666 about?
NCT01485666 is a clinical study titled "Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study". The purpose of this study is to evaluate the feasibility of a Percutaneous Lead Management Kit for HeartMate II driveline stabilization and exit site management.
What is the current status of trial NCT01485666?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-05. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01485666?
The interventions under investigation include: Percutaneous Lead Management Kit (OTHER).
Who is sponsoring clinical trial NCT01485666?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.